BUZZ-West Pharma shares rise after completing credit facility refinancing

October 26 - ** West Pharmaceutical Services (WST.N) shares rose 3.4% in after-hours trading, to $408.18

** According to regulatory filings, the company terminated its existing 2019 credit agreement after repaying the remaining $130 million outstanding debt

** West Pharmaceutical Services (link) signed a new five-year financing agreement, which includes a $750 million revolving credit facility and a $200 million term loan

** The new financing arrangement provides greater financial flexibility for working capital, capital expenditures, acquisitions, and other corporate purposes

** The company stated that the termination of its original credit agreement did not incur any prepayment penalties

** As of the close of the previous trading day, the stock had gained 43.5% so far this year

(To facilitate non-English speakers, Reuters has automatically translated its report into several other languages. As automated translation may contain errors or lack the necessary context, Reuters does not guarantee the accuracy of automated translation and provides it only for reader convenience. Reuters accepts no responsibility for any harm or loss resulting from the use of the automated translation feature.)